SCHEMBL12495990

SCHEMBL12495990

CC1(C)CNC(=O)c2ccc(-c3nc(-c4ccc(C5(C#N)CC5)cc4)cnc3N)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 1/20 0.39
▸ ATR Q13535 6/20 0.34
▸ CDC7 O00311 1/20 0.34
▸ CHEK1 O14757 1/20 0.33
▸ FGFR1 P11362 2/20 0.33
▸ FGFR4 P22455 1/20 0.33
▸ FGFR2 P21802 1/20 0.33
▸ FGFR3 P22607 1/20 0.33
▸ NEK2 P51955 3/20 0.32
▸ TYRO3 Q06418 1/20 0.32
▸ MAP4K1 Q92918 1/20 0.32
▸ KCNH2 Q12809 2/20 0.32
▸ ALOX5AP P20292 1/20 0.32
▸ FEN1 P39748 1/20 0.32
▸ PRKDC P78527 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ PIK3C2A O00443 1/20 0.31
▸ PIK3C2B O00750 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ MTOR P42345 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12495641 0.94 MAP4K4 (0.36) MAP4K4ATRCDC7CHEK1KCNH2
SCHEMBL12077563 0.90 MAP4K4 (0.39) MAP4K4ATRCDC7CHEK1FGFR1
SCHEMBL12495768 0.84 MAP4K4 (0.40) MAP4K4ATRCHEK1FGFR1FGFR4
SCHEMBL12077344 0.83 MAPK1 (0.44) MAP4K4ATR
SCHEMBL12077536 0.80 MAP4K4 (0.45) MAP4K4
SCHEMBL12495807 0.80 MAP4K4 (0.49) MAP4K4CDC7MAP4K1KCNH2
SCHEMBL12495678 0.79 MAP4K4 (0.38) MAP4K4ATRCHEK1KCNH2ALOX5AP
SCHEMBL12076937 0.79 MAP4K4 (0.38) MAP4K4ATRCHEK1KCNH2ALOX5AP
SCHEMBL18937023 0.78 MAPK1 (0.49) MAP4K4ATRCHEK1
SCHEMBL18937027 0.77 ATR (0.45) MAP4K4ATRFGFR1FGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2681206-B1 MST1 KINASE INHIBITORS AND METHODS OF THEIR USE LEXICON PHARMACEUTICALS INC (US) 2017-06-14 — — EP disclosed
EP-2681206-A1 MST1 KINASE INHIBITORS AND METHODS OF THEIR USE Lexicon Pharmaceuticals, Inc. (US) 2014-01-08 — — EP disclosed
WO-2012121992-A1 MST1 KINASE INHIBITORS AND METHODS OF THEIR USE LEXICON PHARMACEUTICALS, INC. (US) 2012-09-13 — — WO disclosed
Send feedback